Seoul, Jan 22 (IANS) South Korea has launched a joint public-private initiative to collect biological data from 1 million individuals, aiming to enhance the global competitiveness of the country’s bio-industry, the country’s finance ministry said on Wednesday.
The ministry said that the project will gather biological samples, such as blood, urine, and biopsies from participants, including those with rare and severe diseases, to create a large-scale dataset, Yonhap news agency reported.
The dataset will be shared with the medical community, academia, and industries, with long-term plans to make it accessible to the general public.
The first phase, supported by 603.9 billion won ($420.6 million) in state investment, aims to collect data from 770,000 people by 2028, the ministry said.
The final target is to reach 1 million participants by 2032.
“This large biological dataset will enhance public health through personalised medical services and drive innovation in the bio industry,” said Shin Sang-hoon, a ministry official, in a meeting with industry officials.
The government emphasised its commitment to collaborating with genetic analysis firms participating in the project, as well as helping bio companies strengthen their global competitiveness.
Meanwhile, the country’s science ministry recently said it has designated 10 technologies that will innovate the bio-industry in the next decade.
According to the Ministry of Science and ICT, the technologies are human immunome, multi-cancer early detection, ribonucleic acid structurome, artificial intelligence (AI)-designed gene editors, anti-ageing antibodies, molecular glue, motile living biobots, digital artificial organs, bio foundation model and health care digital twin, Yonhap reported.
The paradigm of bioresearch will likely change to AI-based prediction and inference from the current research centered on repetitive experiments and observation, the ministry explained.
The technologies will likely be applied in bio and other industries, including medical, space, and manufacturing, in the next five to 10 years.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
